Impaired seroconversion after SARS-CoV-2 mRNA vaccines in patients with solid tumours receiving anticancer treatment

BACKGROUND: Patients with solid tumours have high COVID-19 mortality. Limited and heterogeneous data are available regarding the immunogenicity of SARS-CoV-2 mRNA vaccines in this population. METHODS AND FINDINGS: This is a prospective, single-centre cohort study aiming at evaluating seroconversion...

Descripción completa

Detalles Bibliográficos
Autores principales: Amatu, Alessio, Pani, Arianna, Patelli, Giorgio, Gagliardi, Oscar M., Loparco, Marina, Piscazzi, Daniele, Cassingena, Andrea, Tosi, Federica, Ghezzi, Silvia, Campisi, Daniela, Grifantini, Renata, Abrignani, Sergio, Siena, Salvatore, Scaglione, Francesco, Sartore-Bianchi, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692068/
https://www.ncbi.nlm.nih.gov/pubmed/35032813
http://dx.doi.org/10.1016/j.ejca.2021.12.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692068/
https://www.ncbi.nlm.nih.gov/pubmed/35032813
http://dx.doi.org/10.1016/j.ejca.2021.12.006

Ejemplares similares